CollPlant Biotechnologies Ltd. CLGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | 18.55% | 17.30% | 20.50% | 65.39% | |
| Total Depreciation and Amortization | -13.97% | -10.74% | -12.26% | -12.86% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -38.97% | -109.04% | -55.56% | -7.23% | |
| Change in Net Operating Assets | -92.61% | 148.35% | 168.70% | -239.27% | |
| Cash from Operations | 4.39% | 15.27% | 37.88% | 64.13% | |
| Capital Expenditure | -2,200.00% | 74.58% | 98.51% | 89.02% | |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | 566.67% | 74.14% | 98.84% | 90.24% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -100.00% | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -80.01% | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -110.00% | -110.00% | 133.90% | 100.81% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -343.63% | 14.62% | 116.24% | 65.96% | |